Aprea Therapeutics, Inc. (APRE)

Cash & Short-Term Investments

$41.23M

Quarterly · Period ending: · USD

APRE logo

APRE Cash & Short-Term Investments

Latest reported$41.23M
APRE Quarterly Cash & Short-Term Investments ($65.68M → $41.23M)
High-resolution chart · PNG

APRE cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
41,233,428
46,466,202
14,599,347
13,718,052
16,532,199
19,275,721
22,849,885
26,249,625
28,694,694
32,369,973
21,606,820
25,353,513
27,685,131
30,995,714
28,786,647
33,112,601
39,062,415
47,651,774
53,076,052
61,428,404
69,803,845
77,616,074
89,017,686
101,146,633
112,861,504
122,513,357
130,088,869
52,334,102
60,994,738
65,675,931
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.